The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2017 | The pathologist in cancer care
Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, Scotland speaks about the increasingly vital role of the pathologist in the diagnosis and treatment of cancer patients. Pathologists not only carry out analysis to determine and diagnose disease but they also advise physicians on the most suitable treatment for the patient. This interview was recorded at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland.
